Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Published Erratum

Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients

Christoph Kreer et al. Cell. .
No abstract available

PubMed Disclaimer

Figures

Figure 3
Figure 3
Infected individuals can develop potent near-germline SARS-CoV-2-neutralizing antibodies that preferentially bind to the S-protein RBD (corrected)
Figure 3
Figure 3
Infected individuals can develop potent near-germline SARS-CoV-2-neutralizing antibodies that preferentially bind to the S-protein RBD (original)
Figure 4
Figure 4
Dynamics of somatic mutations for SARS-CoV-2-specific antibodies (corrected)
Figure 4
Figure 4
Dynamics of somatic mutations for SARS-CoV-2-specific antibodies (original)
Figure S3
Figure S3
Correlation of binding and neutralization with VH gene characteristics (corrected)
Figure S3
Figure S3
Correlation of binding and neutralization with VH gene characteristics (original)
Figure S4
Figure S4
VL gene distribution in non-neutralizing and neutralizing antibodies (corrected)
Figure S4
Figure S4
VL gene distribution in non-neutralizing and neutralizing antibodies (original)
Figure S5
Figure S5
Autoreactivity of selected SARS-CoV-2-binding and -neutralizing antibodies (corrected)
Figure S5
Figure S5
Autoreactivity of selected SARS-CoV-2-binding and -neutralizing antibodies (original)
See this image and copyright information in PMC

Erratum for

  • Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients.
    Kreer C, Zehner M, Weber T, Ercanoglu MS, Gieselmann L, Rohde C, Halwe S, Korenkov M, Schommers P, Vanshylla K, Di Cristanziano V, Janicki H, Brinker R, Ashurov A, Krähling V, Kupke A, Cohen-Dvashi H, Koch M, Eckert JM, Lederer S, Pfeifer N, Wolf T, Vehreschild MJGT, Wendtner C, Diskin R, Gruell H, Becker S, Klein F. Kreer C, et al. Cell. 2020 Aug 20;182(4):843-854.e12. doi: 10.1016/j.cell.2020.06.044. Epub 2020 Jul 13. Cell. 2020. PMID: 32673567 Free PMC article.

Publication types